Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Veeva Vault Safety is an advanced system designed for the management of individual case safety reports, facilitating the collection, processing, and reporting of adverse events related to both clinical trials and marketed products. This comprehensive platform allows sponsors and contract research organizations (CROs) to handle both global and local adverse events for various categories, including drugs, biologics, vaccines, devices, and combination products. Its integrated gateway connections and established reporting protocols enhance the efficiency of submitting cases to regulatory authorities and sharing information with partners. Additionally, the centralized management of coding dictionaries automates updates for MedDRA, WHODrug, and EDQM on a semi-annual basis. By consolidating pharmacovigilance processes within a single cloud environment, Vault Safety promotes proactive measures in ensuring patient safety. The system also utilizes real-time reports and dashboards, coupled with seamless collaboration, to enhance visibility and ensure compliance regarding adverse event reporting. Ultimately, this innovative solution transforms the approach to safety management in the pharmaceutical industry, fostering a more efficient and effective response to patient safety concerns.
Description
VigiLanz Vaccinate offers comprehensive oversight of the entire vaccination journey, facilitating large-scale vaccination efforts while simultaneously addressing COVID-19 risk within organizations. This platform allows healthcare professionals to swiftly register individuals and obtain necessary consent. By automating workflows and eliminating the need for manual data entry, program administrators can work more efficiently. Furthermore, it helps minimize vaccine waste through real-time analytics that align volume needs with scheduling and demand. Users benefit from immediate insights into vaccination and immunity statistics at various levels, including individual, departmental, hospital, and organizational. The system also streamlines data collection for CDC and state compliance, encompassing reports on adverse side effects. In addition, it allows for the pre-registration of vaccine recipients, evaluates workforce readiness, consolidates immunity data from external sources, gathers reports on adverse reactions, and manages consent documentation. Healthcare workers can be expedited through the vaccination process with streamlined forms, while automated reminders ensure timely registration for follow-up doses and the reporting of any adverse events. This holistic approach not only enhances the efficiency of vaccination programs but also fosters a more organized response to immunization needs.
API Access
Has API
No
API Access
Has API
No
Integrations
DoseMeRx
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Veeva
Country
United States
Website
www.veeva.com/products/vault-safety/
Vendor Details
Company Name
VigiLanz
Founded
2001
Country
United States
Website
vigilanzcorp.com/vaccinate/
Product Features
Product Features
Vaccine Management
Adverse Reaction Reporting
No
Alerts / Notifications
No
Appointment Reminders
No
Billing
No
Communication Tools
No
Dose Tracking
No
For Governments
No
Immunization Proof
No
Inventory Management
No
Predictive Analytics
No
Scheduling
No
Virtual Waiting Room
No